Form 4: Bank7 Corp. CEO Thomas Travis L. Executes Stock Option Exercises and Sales
SEC Form 4 Filing
Bank7 Corp.'s CEO, Thomas Travis L., recently executed stock option exercises and sales, resulting in adjustments to his beneficial ownership of the company's common stock.
Summary
- On November 7 and 8, 2024, Thomas Travis L., the President & CEO of Bank7 Corp., engaged in transactions involving the company's common stock.
- He exercised employee stock options to acquire shares at prices of $19 and $14.39.
- Concurrently, he sold shares at weighted average prices of $45.3781 and $44.0343.
- These transactions altered his direct ownership of Bank7 Corp. common stock.
- Following these transactions, Travis directly owns 288,271 shares of common stock.
- The reported transactions also involved derivative securities, specifically employee stock options.
- The filing includes details about restricted stock units vesting over several years.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock ownership changes.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Comparing Bank7 Corp. to similar regional banks, insider transactions are a common occurrence.
- For example, executives at companies like Simmons First National Corporation (SFNC) and Prosperity Bancshares, Inc. (PB) also regularly report similar transactions.
- The scale of these transactions is typical for CEOs of companies with similar market capitalizations.
Stakeholder Impact
- Shareholders may be interested in these transactions as they provide insight into management's actions regarding their stock holdings.
- The transactions themselves have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 01/06/2021 | Start date for vesting of 1,000 restricted stock units in five equal installments. |
| 01/04/2022 | Start date for vesting of 2,500 restricted stock units in four equal installments. |
| 12/17/2022 | Start date for vesting of 7,500 restricted stock units in four equal installments. |
| 02/15/2024 | First vesting date for 13,535 restricted stock units in three equal installments. |
| 11/07/2024 | Date of stock option exercise and sale transactions. |
| 11/08/2024 | Date of stock option exercise and sale transactions. |
| 02/15/2025 | Second vesting date for 16,486 restricted stock units in three equal installments. |
| 02/15/2026 | Third vesting date for 16,486 restricted stock units in three equal installments. |
| 02/15/2027 | Final vesting date for 16,486 restricted stock units. |
| 09/19/2028 | Expiration date for employee stock options exercised on 11/07/2024 and 11/08/2024. |
| 01/04/2031 | Expiration date for employee stock options exercised on 11/08/2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.